Mato
ShowsHow it worksAI talentsFree toolsPricing
Book a demo
ShowsHow it worksAI talentsFree toolsPricingSign in
Mato
Mato

The first generation of AI talents. Live AI media for brands, networks and creators.

ElevenLabs GrantsAWS ActivateGoogle for StartupsNVIDIA Inception Program

Product

  • How it works
  • AI talents
  • Documentation
  • The studio
  • Pricing
  • Embed player
  • Mato MCP
  • Mato Voice
  • Voice Studio
  • Changelog

Company

  • About
  • Vision
  • Partners
  • Affiliates
  • Blog
  • CustomersComing soon
  • CareersComing soon
  • Press kit
  • Contact

Resources

  • Investor overview
  • Free podcast tools
  • Free podcast transcription
  • Podcast ROI calculator
  • API docsComing soon
  • SecurityComing soon
  • StatusComing soon

© 2026 Mato. All rights reserved.

English · Multiple languages available

PrivacyTerms

Live Interview

And why does that matter?

This is how a Mato agent talks. Take the other seat: answer a few and feel it follow the thread.

Try it yourself

Podcast charts

Joint Approach

Published by Musculoskeletal Infection Society

  • Science
  • Natural sciences

The goal of this podcast is to have both infectious disease physicians and orthopedic surgeons sit down to discuss the “joint” prevention, diagnosis and management of musculoskeletal infections. We break down the existing data and open the lines of communication between the medical and surgical specialties to help navigate these challenging clinical cases.

Listen on Apple Podcasts, opens in a new tabMake something like it

On the charts

6 chart placements

Every published chart this podcast appears in, in the snapshot behind this page. Each one links to the chart it came off.

  1. Number 114Natural sciencesAustralia
  2. Number 35Natural sciencesCanada
  3. Number 56Natural sciencesUnited Kingdom
  4. Number 9Natural sciencesNorway
  5. Number 90ScienceNorway
  6. Number 72Natural sciencesUnited States

From the feed

Recent episodes

The latest episodes published to this podcast’s own RSS feed. Titles and descriptions are the publisher’s.

  1. Candidal PJI's: Uncommon and Unforgettable, Part 1 from Joint Approach, opens in a new tab

    Sep 8, 202626 min

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with MartinMcNally, MD FRCSEd FRCS(Orth) and Aurélien Dinh, MD, PhD in part 1 of this 2-part conversation on candidal prosthetic joint infections. FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  2. Does the "5-second" Rule Apply to Dropped Medical Objects in the OR? from Joint Approach, opens in a new tab

    Aug 18, 202629 min

    Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD, and guests Sam Rosas, MD, PhD, David Weber, MD, MPH, and Bobby Warren, MPS, as they review the artcile entitled: "The "five-second" rule for dropped food: does it apply to dropped medical objects in the operating room? A randomized study of disinfection approaches for contaminated arthroplasty implants." Click here to access the abstract from the Journal: Infection Control and Hospital Epidemiology, March 26, 2026. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com , or visit Peptilogics.com . FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  3. Bugged and Baffled: A Case with Meredith Schade, Kelan Queenan, and Kevin Perry Part 2 from Joint Approach, opens in a new tab

    Aug 4, 202628 min

    In the conclusion of this challenging case discussion, Jessica Seidelman, MD and Johannes Plate, MD, PhD continue the conversation and the big reveal with Meredith Schade, MD, Kevin Perry, MD, and medical school student Kelan Queenan. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN ® , NanoBone ® , genex ® , and SYNICEM TM , please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  4. Bugged and Baffled: A Case with Meredith Schade, Kelan Queenan, and Kevin Perry- Part 1 from Joint Approach, opens in a new tab

    Jul 21, 202628 min

    Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In part 1 of this 2-part series, they discuss a challenging case with Meredith Schade, MD, Kevin Perry, MD, and medical school student Kelan Queenan. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN ® , NanoBone ® , genex ® , and SYNICEM TM , please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  5. Lysins: A Next Generation Treatment Option for PJI? Part 2 from Joint Approach, opens in a new tab

    Jul 7, 202626 min

    In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Gina Suh, MD, Ken Urish, MD, PhD, and Ray Schuch, PhD on the topic of innovation in treatment of PJI's with phage lysins. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN ® , NanoBone ® , genex ® , and SYNICEM TM , please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  6. Lysins: A Next Generation Treatment Option for PJI? Part 1 from Joint Approach, opens in a new tab

    Jun 23, 202627 min

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Gina Suh, MD, Ken Urish, MD, PhD, and Ray Schuch, PhD in part 1 of this 2-part conversation on the topic of innovation in treatment of PJI's with phage lysins. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN ® , NanoBone ® , genex ® , and SYNICEM TM , please click here

  7. ICM Guidelines Discussion: “Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?” Part 2 from Joint Approach, opens in a new tab

    Jun 9, 202627 min

    In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with P. Maxwell Courtney, MD, Katherine Belden, MD, Poorani Sekar, MD on the topic of long term antibiotic usage at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com , or visit Peptilogics.com . FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  8. ICM Guidelines Discussion: “Should prolonged antimicrobials be given to patients who have undergone recent reimplantation surgery with all cultures being negative?” Part 1 from Joint Approach, opens in a new tab

    May 19, 202626 min

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with P. Maxwell Courtney, MD, Katherine Belden, MD, and Poorani Sekar, MD in part 1 of this 2-part conversation on the topic of long term antibiotic usage at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to Peptilogics for sponsoring this episode. For more information about their clinical trials, email clinicaltrials@peptilogics.com , or visit Peptilogics.com . FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  9. ICM Guidelines Discussion: "Is there a role for suppressive antibiotic treatment (SAT) only in patients with PJI?” Part 2 from Joint Approach, opens in a new tab

    May 5, 202626 min

    In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Michael Henry, MD and Daisuke Furukawa, MD on the topic of Suppressive Antibiotic Therapy (SAT) at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com .

  10. ICM Guidelines Discussion: "Is there a role for Suppressive Antibiotic Treatment only in patients with PJI?” Part 1 from Joint Approach, opens in a new tab

    Apr 21, 202630 min

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Michael Henry, MD and Daisuke Furukawa, MD in part 1 of this 2-part conversation on the topic of Suppressive Antibiotic Therapy at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  11. ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 2 from Joint Approach, opens in a new tab

    Apr 7, 202628 min

    In the final episode of this 2-part series, Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Here are the ICM links: DOCUMENTS | ICMORTHO. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com . FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  12. ICM Guidelines Discussion: "Why does antibiotic duration after DAIR for PJI matter?" Part 1 from Joint Approach, opens in a new tab

    Mar 24, 202626 min

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Alaina Ritter, MD, Geno Tai, MD, and Sumon Nandi, MD in part 1 of this 2-part conversation on the topic of antibiotic duration following DAIR in PJI analyzed at The International Consensus Meeting in Istanbul, Turkey, May 2025. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  13. Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 2 from Joint Approach, opens in a new tab

    Mar 10, 202629 min

    In the final episode of this 2-part series, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the conversation on Shoulder PJI definition evolution with Surena Namdari, MD, and Jason Hsu, MD. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com .

  14. Shouldering the Burden: A New Era for Diagnosing Shoulder Prosthetic Joint Infections Part 1 from Joint Approach, opens in a new tab

    Feb 17, 202634 min

    Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they chat with Surena Namdari, MD, and Jason Hsu, MD in part 1 of this 2-part conversation on Shoulder PJI definition evolution. Thanks to bioMérieux for sponsoring this episode. For more information about their BIOFIRE® Joint Infection (JI) Panel and molecular diagnostics solutions, please visit bioMérieux.com . FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com .

  15. Bugged and Baffled: A Case with Meredith Schade and Stephanie Hawkins from Joint Approach, opens in a new tab

    Feb 3, 202627 min

    Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD in this Case Study Series entitled Bugged and Baffled. In this episode, they discuss a challenging case with Meredith Schade, MD, and Stephanie Hawkins, MD. Thanks to Biocomposites for sponsoring this episode. For more information about Biocomposites products STIMULAN®, NanoBone®, and genex®, please click here FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  16. Dalbavancin/Oritavancin for treatment of PJI Part 3 from Joint Approach, opens in a new tab

    Jan 20, 202622 min

    In the conclusion of this series on long-acting antibiotics, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they wrap up the conversation with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, PhD in the first episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  17. Dalbavancin/Oritavancin for treatment of PJI Part 2 from Joint Approach, opens in a new tab

    Jan 6, 202622 min

    Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they continue the in-depth discussion on long-lasting antibiotics with Vance Fowler,MD, MHS, Thomas Holland, and Thomas Lodise, PharmD, PhD in the second episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode.For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  18. Dalbavancin/Oritavancin for Treatment of PJI Part 1 from Joint Approach, opens in a new tab

    Dec 16, 202525 min

    Join hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD as they have an in-depth discussion about long-lasting antibiotics with Vance Fowler, MD, MHS, Thomas Holland, MD, and Thomas Lodise, PharmD, PhD in the first episode of this three-part series. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  19. The Psychosocial Impact of Orthopedic Joint Infections from Joint Approach, opens in a new tab

    Dec 2, 202534 min

    In this follow-up conversation from the International Consensus Meeting on Infection, hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD chat with Allison Lastinger, MD, FACP, and Ran Schwarzkopf, MD about the question: “How can we capture the physical and psychological impact of orthopedic infections on patients?” FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

  20. Spinal Implant Infections Part 2 from Joint Approach, opens in a new tab

    Nov 18, 202534 min

    Hosts Jessica Seidelman, MD and Johannes Plate, MD, PhD conclude the discussion on spinal implant infections with Geno Tai, MD, and Francis Lovecchio, MD. Thanks to Osteal Therapeutics for sponsoring this episode. For more information about VT-X7, including the APEX clinical trials results, please visit Ostealtx.com FOLLOW us on X @jointapproach or Instagram @jointapproachpodcast for more announcements and content, and reach out to us at jointapproachpodcast@gmail.com

Ranking source

Apple Podcasts rankings via the Mato Topic Intelligence Platform.

Observed September 20, 2026.

Apple and Apple Podcasts are trademarks of Apple Inc., registered in the U.S. and other countries.

Pairs with

What to do with a chart

01ShowsThe shows Mato publishesEvery public Mato show, its episodes, and the Apple placements it holds.02AI talentPick the voice before the formatThe live roster of hosts, each with samples you can listen to before you commit.03How it worksFrom an idea to a published episodeWhat Mato does between the brief and the feed, step by step.

Steal the structure, not the show

Bring this source into Mato to read its transferable patterns, then turn them into an original show for your own audience.

Hear a Mato showCreate a show inspired by this